Trademark: 88155279
Status Date
Monday, December 20, 2021
Filing Date
Monday, October 15, 2018
Published for Opposition
Tuesday, March 24, 2020
Abandoned Date
Monday, December 20, 2021
5 Pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; Pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; Pharmaceutical preparations for human use for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of endocrine diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of hormonal diseases, disorders and conditions; Pharmaceutical preparations for human use for the treatment of genetic diseases, disorders and conditions
The mark consists of a triangular logo.
Color is not claimed as a feature of the mark.
Dec 20, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 20, 2021
Abandonment - No Use Statement Filed
May 29, 2021
Notice Of Approval Of Extension Request E-Mailed
May 28, 2021
Sou Extension 2 Granted
May 19, 2021
Sou Extension 2 Filed
May 27, 2021
Case Assigned To Intent To Use Paralegal
May 24, 2021
Assigned To Examiner
May 19, 2021
Teas Extension Received
Oct 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2020
Sou Extension 1 Granted
Oct 28, 2020
Sou Extension 1 Filed
Oct 28, 2020
Teas Extension Received
May 19, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 24, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 24, 2020
Published For Opposition
Mar 4, 2020
Notification Of Notice Of Publication E-Mailed
Feb 18, 2020
Assigned To Lie
Feb 11, 2020
Approved For Pub - Principal Register
Feb 11, 2020
Examiner's Amendment Entered
Feb 11, 2020
Notification Of Examiners Amendment E-Mailed
Feb 11, 2020
Examiners Amendment E-Mailed
Feb 11, 2020
Examiners Amendment -Written
Aug 15, 2019
Notification Of Final Refusal Emailed
Aug 15, 2019
Final Refusal E-Mailed
Aug 15, 2019
Final Refusal Written
Jul 25, 2019
Teas/Email Correspondence Entered
Jul 24, 2019
Correspondence Received In Law Office
Jul 24, 2019
Teas Response To Office Action Received
Jan 31, 2019
Notification Of Priority Action E-Mailed
Jan 31, 2019
Priority Action E-Mailed
Jan 31, 2019
Priority Action Written
Jan 24, 2019
Assigned To Examiner
Oct 26, 2018
Notice Of Design Search Code E-Mailed
Oct 25, 2018
New Application Office Supplied Data Entered In Tram
Oct 18, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
